91 related articles for article (PubMed ID: 16685448)
21. Sulindac activates NF-κB signaling in colon cancer cells.
Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
[TBL] [Abstract][Full Text] [Related]
22. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
Jang TJ; Kang HJ; Kim JR; Yang CH
Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
[TBL] [Abstract][Full Text] [Related]
23. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
24. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells.
Fogli S; Banti I; Stefanelli F; Picchianti L; Digiacomo M; Macchia M; Breschi MC; Lapucci A
Eur J Med Chem; 2010 Nov; 45(11):5100-7. PubMed ID: 20801552
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest.
Flis S; Soltysiak-Pawluczuk D; Jedrych A; Jastrzebski Z; Remiszewska M; Splawinski J
Anticancer Res; 2006; 26(4B):3033-41. PubMed ID: 16886631
[TBL] [Abstract][Full Text] [Related]
27. Sulindac induces apoptosis, inhibits proliferation and activates caspase-3 in Hep G2 cells.
Liu JJ; Wang JY; Hertervig E; Nilsson A; Duan RD
Anticancer Res; 2002; 22(1A):263-6. PubMed ID: 12017300
[TBL] [Abstract][Full Text] [Related]
28. Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition.
Bock JM; Menon SG; Goswami PC; Sinclair LL; Bedford NS; Jackson RE; Trask DK
Cancer Biol Ther; 2007 Jan; 6(1):30-9. PubMed ID: 17172818
[TBL] [Abstract][Full Text] [Related]
29. Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction.
Seo SK; Lee HC; Woo SH; Jin HO; Yoo DH; Lee SJ; An S; Choe TB; Park MJ; Hong SI; Park IC; Rhee CH
Apoptosis; 2007 Jan; 12(1):195-209. PubMed ID: 17136320
[TBL] [Abstract][Full Text] [Related]
30. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
Liou JY; Ghelani D; Yeh S; Wu KK
Cancer Res; 2007 Apr; 67(7):3185-91. PubMed ID: 17409426
[TBL] [Abstract][Full Text] [Related]
32. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.
Zhou H; Liu W; Su Y; Wei Z; Liu J; Kolluri SK; Wu H; Cao Y; Chen J; Wu Y; Yan T; Cao X; Gao W; Molotkov A; Jiang F; Li WG; Lin B; Zhang HP; Yu J; Luo SP; Zeng JZ; Duester G; Huang PQ; Zhang XK
Cancer Cell; 2010 Jun; 17(6):560-73. PubMed ID: 20541701
[TBL] [Abstract][Full Text] [Related]
33. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
Singh R; Cadeddu RP; Fröbel J; Wilk CM; Bruns I; Zerbini LF; Prenzel T; Hartwig S; Brünnert D; Schroeder T; Lehr S; Haas R; Czibere A
Apoptosis; 2011 Sep; 16(9):889-901. PubMed ID: 21739277
[TBL] [Abstract][Full Text] [Related]
34. Uncoupling of oxidative phosphorylation and Smac/DIABLO release are not sufficient to account for induction of apoptosis by sulindac sulfide in human colorectal cancer cells.
Daouphars M; Koufany M; Benani A; Marchal S; Merlin JL; Netter P; Jouzeau JY
Int J Oncol; 2005 Apr; 26(4):1069-77. PubMed ID: 15754004
[TBL] [Abstract][Full Text] [Related]
35. Sulindac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2.
Lee HC; Park IC; Park MJ; An S; Woo SH; Jin HO; Chung HY; Lee SJ; Gwak HS; Hong YJ; Yoo DH; Rhee CH; Hong SI
J Cell Biochem; 2005 Feb; 94(3):597-610. PubMed ID: 15546138
[TBL] [Abstract][Full Text] [Related]
36. Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition.
Bock JM; Menon SG; Goswami PC; Sinclair LL; Bedford NS; Domann FE; Trask DK
Mol Carcinog; 2007 Oct; 46(10):857-64. PubMed ID: 17415779
[TBL] [Abstract][Full Text] [Related]
37. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC.
Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML
Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
39. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
40. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA
Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
